摘要:
1,2,3 Triazines according to formula (I): and pharmaceutically acceptable salts thereof inhibit phosphorylation of platelet-derived growth factor receptor and thereby hinder abnormal cell growth and cell wandering.
摘要:
1,3 Diazines according to formula: and pharmaceutically acceptable salts thereof inhibit phosphorylation of platelet-derived growth factor receptor and thereby hinder abnormal cell growth and cell wandering.
摘要:
1,3 Diazines according to formula (I): and pharmaceutically acceptable salts thereof inhibit phosphorylation of platelet-derived growth factor receptor and thereby hinder abnormal cell growth and cell wandering. The compounds may be used to treat or prevent cell-proliferative disorders such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis.
摘要:
1,3 Diazines and pharmaceutically acceptable salts thereof inhibit phosphorylation of platelet-derived growth factor receptor and thereby hinder abnormal cell growth and cell wandering. The compounds may be used to treat or prevent cell-proliferative disorders such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis.
摘要:
The present invention relates to an adenosine uptake inhibitor and an agent for the myocardium protection or the prevention or treatment of inflammatory edema, comprising a 1,2,3,4-tetrahydro-2,4-dioxoquinazoline derivative represented by formula (I): ##STR1## wherein R.sup.1 represents hydrogen, substituted or unsubstituted lower alkyl, alkenyl, or substituted or unsubstituted aralkyl; R.sup.2, R.sup.3, R.sup.4, and R.sup.5 independently represent hydrogen, halogen, amino, mono- or di(lower alkyl)amino, lower alkanoylamino, nitro, cyano, substituted or unsubstituted lower alkyl, hydroxy, lower alkoxy, lower alkylthio, carboxy, lower alkoxycarbonyl, lower alkanoyl, aralkyloxy, or lower alkanoyloxy; R.sup.6, R.sup.7, R.sup.8, and R.sup.9 independently represent hydrogen, hydroxy, substituted or unsubstituted lower alkoxy, or aralkyloxy, or any adjoining two of them are combined to form methylenedioxy; R.sup.10 represents hydrogen or lower alkyl; and Y and Z independently represent N or C-R.sup.11 (wherein R.sup.11 represents hydrogen, substituted or unsubstituted lower alkyl, or halogen),or a pharmaceutically acceptable salt thereof as an active ingredient.
摘要翻译:本发明涉及腺苷摄取抑制剂和用于心肌保护或预防或治疗炎性水肿的药剂,其包含由式(I)表示的1,2,3,4-四氢-2,4-二氧代喹唑啉衍生物: (I)其中R 1表示氢,取代或未取代的低级烷基,烯基或取代或未取代的芳烷基; R2,R3,R4和R5独立地表示氢,卤素,氨基,一或二(低级烷基)氨基,低级烷酰基氨基,硝基,氰基,取代或未取代的低级烷基,羟基,低级烷氧基,低级烷硫基,羧基,低级 烷氧基羰基,低级烷酰基,芳烷氧基或低级烷酰氧基; R 6,R 7,R 8和R 9独立地表示氢,羟基,取代或未取代的低级烷氧基或芳烷氧基,或者它们中的任何相邻的两个被结合形成亚甲二氧基; R 10表示氢或低级烷基; 并且Y和Z独立地表示作为活性成分的N或C-R11(其中R11表示氢,取代或未取代的低级烷基或卤素)或其药学上可接受的盐。
摘要:
A drive device includes two integrated electromagnetic coils separated on an axis, an elastic body, and two movable electric conductors. An object-to-be-moved is moved to left with an operation of a left group which includes one electromagnetic coil and one conductor. A first conductor is repulsively moved to right by a repulsion force caused by an eddy current generated on the first conductor with an electrical current-supply to a first electromagnetic coil and then, the elastic body is compressed by the first conductor and subsequently pushes back the first conductor. At this time, the electrical current-supply to the first electromagnetic coil is turned off, and the first conductor collides with the first electromagnetic coil, and this collision generates a leftward impact. The left and right groups enable a left-right reciprocating movement.
摘要:
In a generating method and a generator of mist or fine-bubble, with a simple and small configuration, application into a wide range kind of liquid is enabled, and generating stably the mist or the fine-bubbles or both is enabled. The generator is provided with a piezoelectric substrate which equips two or more comb-like electrodes on a surface and arranged so that the surface may intersect the mutual interface of the gas and the liquid and a part of piezoelectric substrate is put in a liquid, and a surface acoustic wave excited on the surface with the electrode is made to propagate along the surface so that may exist in the upper and lower sides of an interface. The surface acoustic wave generates mist in the gas side which is above the interface, and generates fine-bubbles in the liquid side which is below the interface. Since the mist and the fine-bubbles are generated with the surface acoustic wave, without being based on mechanical operation for generating a turning stream, the mist and the fine-bubbles can be stably generated in the simple and small configuration.
摘要:
Disclosed are quinazoline derivatives represented by formula (I): wherein R.sup.1 represents hydrogen, lower alkyl, alkenyl, or aralkyl; R.sup.2, R.sup.3, R.sup.4, and R.sup.5 represent hydrogen, lower alkyl, lower alkoxy, lower alkanoyl, or the like; R.sup.6, R.sup.7, R.sup.8, and R.sup.9 represent hydrogen, lower alkyl, lower alkoxy, aralkyloxy, or the like, or any adjoining two of them are combined to form methylenedioxy or the like; R.sup.10 represents hydrogen, lower alkyl, or the like; R.sup.11 and R.sup.12 represent hydrogen, lower alkyl, cycloalkyl, phenyl, or aralkyl, or R.sup.11 and R.sup.12 are combined together with N to form a heterocyclic group; and n represents 0, 1 or 2, and pharmaceutically acceptable salts thereof. These compounds have adenosine uptake inhibitory activity and are useful for the protection of myocardium and for the prevention or treatment of renal diseases such as nephritis and diabetic nephropathy.
摘要翻译:公开了由式(I)表示的喹唑啉衍生物:其中R1表示氢,低级烷基,烯基或芳烷基; R2,R3,R4和R5代表氢,低级烷基,低级烷氧基,低级烷酰基等; R 6,R 7,R 8和R 9表示氢,低级烷基,低级烷氧基,芳烷氧基等,或者其中任意相邻的两个相结合形成亚甲二氧基等; R 10表示氢,低级烷基等; R 11和R 12表示氢,低级烷基,环烷基,苯基或芳烷基,或R 11和R 12与N一起形成杂环基; 和n表示0,1或2,及其药学上可接受的盐。 这些化合物具有腺苷摄取抑制活性,可用于保护心肌和预防或治疗肾脏疾病如肾炎和糖尿病肾病。
摘要:
The present invention relates to an adenosine uptake inhibitor and an agent for the myocardium protection or the prevention or treatment of inflammatory edema, comprising a 1,2,3,4-tetrahydro-2,4-dioxoquinazoline derivative represented by formula (I): ##STR1## wherein R.sup.1 represents hydrogen, substituted or unsubstituted lower alkyl, alkenyl, or substituted or unsubstituted aralkyl; R.sup.2, R.sup.3, R.sup.4, and R.sup.5 independently represent hydrogen, halogen, amino, mono- or di(lower alkyl)amino, lower alkanoylamino, nitro, cyano, substituted or unsubstituted lower alkyl, hydroxy, lower alkoxy, lower alkylthio, carboxy, lower alkoxycarbonyl, lower alkanoyl, aralkyloxy, or lower alkanoyloxy; R.sup.6, R.sup.7, R.sup.8, and R.sup.9 independently represent hydrogen, hydroxy, substituted or unsubstituted lower alkoxy, or aralkyloxy, or any adjoining two of them are combined to form methylenedioxy; R.sup.10 represents hydrogen or lower alkyl; and Y and Z independently represent N or C--R.sup.11 (wherein R.sup.11 represents hydrogen, substituted or unsubstituted lower alkyl, or halogen),or a pharmaceutically acceptable salt thereof as an active ingredient.
摘要:
A drive device which provides an electromagnetic impact and a movement mechanism using the drive device to achieve a reciprocating movement with a compact and simple configuration. A drive device provides an impact to an object-to-be-moved supported by a friction surface and moves the object-to-be-moved, and includes an electromagnetic coil, a permanent magnet, a stopper, and a control device which controls the electromagnetic coil. The permanent magnet relatively moves to the electromagnetic coil by an action caused by an electrical current supply to the electromagnetic coil. When the electrical current is supplied to the electromagnetic coil, the permanent magnet collides with the electromagnetic coil or the stopper, which forms the collided-body, and generates the impact. The impact can be generated in any direction, then a reciprocating movement of the object-to-be-moved can be achieved.